Open AccessIntravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
Author(s) -
Tuğba Aydogan,
Gürkan Erdoğan,
Cihan Ünlü,
Ahmet Ergin
Publication year - 2016
Publication title -
turkish journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 10
eISSN - 2147-2661
pISSN - 1300-0659
DOI - 10.4274/tjo.23921
Subject(s) - medicine , macular telangiectasia , ophthalmology , visual acuity , bevacizumab , macular edema , fundus (uterus) , fluorescein angiography , fundus fluorescein angiography , surgery , chemotherapy
To evaluate the efficacy of intravitreal bevacizumab treatment in type 2 idiopathic macular telangiectasia (IMT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom